A carregar...
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis
OBJECTIVES: Advancing age is a risk factor for treatment-related side effects and mortality in AAV patients treated with cyclophosphamide (CYC) and glucocorticoids (GC) for remission induction. The efficacy and safety of rituximab (RTX) in elderly AAV patients has not been well described. METHODS: W...
Na minha lista:
| Publicado no: | Semin Arthritis Rheum |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515385/ https://ncbi.nlm.nih.gov/pubmed/25796088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semarthrit.2015.02.005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|